Flubromazepam

Flubromazepam is a long lasting psychoactive substance of the benzodiazepine class which produces anxiolytic, sedative, muscle relaxant, depressant and amnesic effects.[112][114] This compound was first synthesized in 1960, but was never marketed and did not receive any further attention or study until late 2012 when it appeared on the gray market as a novel designer drug.[112][114] It has potential use for short-term treatment of anxiety, insomnia, acute seizures, and the sedation of hospitalized patients.[112] However, it is currently exclusively sold by online research chemical vendors for use as a recreational psychoactive substance and has not been formally studied.[112] This means that any comments regarding its pharmacology are purely speculation based upon the subjective effects it induces and its structural similarity to triazolam, pyrazolam, and other benzodiazepines.[112]

History

The synthesis of this compound was first described in 1962 by Sternbach et al.[113] Following the appearance of pyrazolam (in 2012), it comes with no surprise that flubromazepam, a designer benzodiazepine, was offered on the market